Compounding Pharmacy · Est. 2007 · Kennesaw, GA · 503A

Innovation Compounding Review

Innovation Compounding is a 503A pharmacy in Kennesaw, Georgia, founded in 2007 as a family-owned operation. Acquired by Revelation Pharma in January 2022. PCAB accreditation granted June 2024 via ACHC. Reportedly serves over 45 states.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

503APCAB
Location: Kennesaw, GA
States licensed: 48
8.2
★★★★☆4.1/5

Editorial score · methodology

Telehealth Providers Sourcing From This Pharmacy

These telehealth brands are reported to fulfill some or all compounded GLP-1 prescriptions through Innovation Compounding. Sourcing arrangements can change over time.

7.1/ 10

LifeMD

Best for: non-GLP-1 weight management

★★★★☆3.6/5

Editorial score · methodology

$149/mosemaglutide
BrandSemaglutideTirzepatide
Get StartedRead full LifeMD review →

Top-Rated GLP-1 Partners

Not sourced from Innovation Compounding — these are our highest-scored vetted telehealth partners for compounded GLP-1s, if you'd rather start with a provider we've walked through end to end.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

No insurance needed · HSA/FSA eligible · vetted by our editors

6.9

YourEra

$99 first-month entry pricing on compounded GLP-1s

Starting price: $149/mo

Get started →Read review YourEra →
8.2

Gala

Compounded GLP-1/GIP combo on a yearly plan with free shipping

Starting price: $149/mo

Get started →Read review Gala →
6.9

TMates

Nationwide compounded GLP-1 availability including Puerto Rico

Starting price: $249/mo

Get started →Read review TMates →
7.9

Trimi Health

Budget-conscious shoppers

Starting price: $99/mo

Get started →Read review Trimi Health →

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

PCAB
Pharmacy Compounding Accreditation Board — voluntary third-party accreditation (operated by ACHC) auditing the pharmacy against nationally recognized quality and safety standards for sterile and non-sterile compounding.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed (48)

ALAKARCACOCTDEFLGAIDILINIAKSKYLAMEMDMAMIMNMSMOMTNENVNHNJNYNCNDOHOKORPARISCSDTNTXUTVTVAWAWVWIWYDC

Regulatory Actions

No public FDA enforcement actions or recalls are on file in our records for Innovation Compounding. Regulatory status can change — verify with the FDA and your state board of pharmacy before relying on this information.

External Reviews

Google Reviews
4.3 / 5.0
Based on 130 reviews

Weight Loss Rankings Score Breakdown

Accreditation & Compliance9/10
Regulatory Standing9/10
State Coverage9/10
GLP-1 Production10/10
Track Record9/10

Scores are independently researched. See our methodology for details.

High confidence · Last verified 2026-04-07 via wave-4-pharmacy-agent · How we verify provider data

Frequently Asked Questions

Innovation Compounding is a 503A compounding pharmacy based in Kennesaw, GA that has been operating since 2007. It holds PCAB accreditation, a voluntary third-party quality standard for compounding pharmacies. We are not aware of any recent public FDA enforcement actions against the pharmacy, though compounding pharmacy regulatory history can change. Always verify current status with your state board of pharmacy.
Innovation Compounding is headquartered in Kennesaw, GA. The pharmacy is licensed to ship to 48 US states.
Innovation Compounding produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a 503A pharmacy, it dispenses compounded medications in response to individual patient prescriptions under state board of pharmacy oversight.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

See Top Semaglutide ProvidersAll Pharmacies
Sources & methodology — as of October 2026
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.